Giuseppe Camporese

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (18)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

In recent years, great efforts have been made to improve decision making in caring for patients of venous thromboembolism (VTE) [...]

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (6)

Walter Ageno

University of Insubria

ITALY

View details

Andrea Ticinesi

Università degli Studi di Pavia

ITALY

View details

Paolo Simioni

Padua University Hospital

ITALY

View details

Luca Spiezia

ITALY

View details

Arcangelo Picciariello

Università del Salento

ITALY

View details

Egidio Imbalzano

Associate Professor

University of Messina

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Giuseppe Camporese

Research Interests

Explore related searches

Contact this professor

Articles (18)

Bacterial Porins and Their Procoagulant Role: Implication in the Pathophysiology of Several Thrombotic Complications during Sepsis

Statins during Anticoagulation for Emergency Life-Threatening Venous Thromboembolism: A Review

Update on the Pharmacological Actions of Enoxaparin in Nonsurgical Patients

Treatment of Superficial Vein Thrombosis: Recent Advances, Unmet Needs and Future Directions

Retrospective analysis on clinical characteristics and venous thromboembolism outcomes using bridging prophylaxis with low molecular weight heparin for thrombophilic women performing oocyte retrieval for assisted reproductive procedures: 15 years of experience

Clinical evidence and rationale of mesoglycan to treat chronic venous disease and hemorrhoidal disease: a narrative review

Editorial on the Special Issue “The New Frontier of Venous Thromboembolism”

Editorial Comment on the Special Issue Discussing COVID-19 and Thrombosis, Second Edition

Common Practice in the Treatment of Superficial Vein Thrombosis Involving the Sapheno-Femoral Junction: Results from a National Survey of the Italian Society of Angiology and Vascular Medicine (SIAPAV)

Aspirin or low-molecular weight heparin for thromboprophylaxis after a fracture? That is the question

Mesoglycan for the secondary prevention of superficial vein thrombosis: a randomized, controlled, double-blind study (METRO Study)—rationale and protocol

Safety and Efficacy of Rivaroxaban as Extended-Phase Anticoagulation in Patients with Cancer and Venous Thromboembolism: A Preliminary Data Analysis from the Mac Project

Editorial COVID-19 and Thrombosis 2023: New Waves of SARS-CoV-2 Infection, Triage Organization in Emergency Department and the Association of VOCs/VOI with Pulmonary Embolism

Safety and Efficacy of Rivaroxaban for Extended-Phase Anticoagulation of Patients with Unprovoked or Recurrent Venous Thromboembolism: Real-Life Data from the MAC Project

Special Issue “COVID-19 and Thrombosis”

Correction: Di Micco et al. Clinical Differences between COVID-19 and a COVID-like Syndrome. J. Clin. Med. 2021, 10, 2519

Risk Factors of Venous Thromboembolism in Noncritically Ill Patients Hospitalized for Acute COVID-19 Pneumonia Receiving Prophylactic-Dose Anticoagulation

Machine Learning to Calculate Heparin Dose in COVID-19 Patients with Active Cancer

Collaborators (6)

Walter Ageno

Andrea Ticinesi

Paolo Simioni

Luca Spiezia

Arcangelo Picciariello

Egidio Imbalzano

Make your next move.